Stock Market & Financial News
What Makes Assurant (AIZ) a New Buy Stock
Assurant (AIZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AIZ Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
Enlivex Ltd. (ENLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ENLV BlackRock TCP (TCPC) Upgraded to Buy: Here's Why
BlackRock TCP (TCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TCPC Amphenol (APH) Upgraded to Buy: Here's What You Should Know
Amphenol (APH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
APH 
ExlService Holdings (EXLS) Upgraded to Buy: What Does It Mean for the Stock?
ExlService Holdings (EXLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
EXLS 
All You Need to Know About Lesaka Technologies (LSAK) Rating Upgrade to Buy
Lesaka Technologies (LSAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LSAK 
One Short- and One Long-Term ETF for Quantum Computing Bulls
Share declines for companies with an exclusive focus on quantum computing have been significant this year—D-Wave Quantum Inc. NYSE: QBTS has dropped a dismal 23% year-to-date (YTD), for instance, while even better-faring rivals like IonQ Inc. NYSE: IONQ are still down 5%. A perfect storm of threats from larger rivals (or up-and-coming new names), continued struggles with marketability and profit, and uneven revenue performance have prompted many companies in the space to slump.
QMCO 
JPMorgan, Morgan Stanley, Bank of America: Three Major Banks, Three Different Verdicts
At current prices: JPMorgan Chase (NYSE:JPM | JPM Price Prediction) at $336.47 looks fully valued, Morgan Stanley (NYSE:MS) at $222.28 appears stretched, and Bank of America (NYSE:BAC) at $59.67 screens as the most attractive on valuation.
MGHL 
JPMorgan Maintains Jamie Dimon Didn't Know Epstein As Sen. Warren Investigates
Warren's letter asks Dimon for a response by July 24, though that is not legally binding. More information about Epstein's relationship with JPMorgan Chase could also come out on July 23, when the House Oversight Committee will interview Staley as part of its ongoing probe into Epstein and his alleged crimes.
JPM 
Hoskinson Fires Back at Cardano Community With a Powerful Call to “Do Something!”
Hoskinson responded harshly to the Cardano community following Solana's deal with SBI Holdings in Japan, rejecting personal responsibility. SBI Holdings announced an alliance with Solana to issue stablecoins and tokenize assets in a region where Cardano historically obtained 90% of its initial funding.
Microsoft's CEO Lays Out the Next Massive AI Trade
Microsoft (NASDAQ:MSFT | MSFT Price Prediction) CEO Satya Nadella published an X essay titled “The Reverse Information Paradox” that has become one of the most-discussed pieces of AI strategy writing of the year.
MSFT 
History Says Buy the Dip on This Struggling Semiconductor Stock
Shares of POET Technologies Inc (NASDAQ:POET) are trading 2.8% lower at $8.08 this afternoon, continuing their consolidation around the $8 floor and extending a pullback from mid-May highs.
POET 
ANI Pharmaceuticals reports Phase 4 data for uveitis eye implant
ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported positive topline data from a Phase 4 trial of its fluocinolone acetonide intravitreal implant in chronic non-infectious uveitis, drawing on results from its open-label SYNCHRONICITY study, the company said. ANI Pharmaceuticals said the SYNCHRONICITY trial was a Phase 4, open-label, single-arm study of the fluocinolone acetonide intravitreal implant in patients with chronic non-infectious uveitis affecting the posterior segment of the eye, a condition the company abbreviated as chronic NIU-PS.
ANIP 
Can CashAI Continue Powering Dave's Credit Growth Momentum Ahead?
DAVE's CashAI improves ExtraCash's credit performance, lifting originations, lowering delinquency and boosting monetization as AI-driven underwriting evolves.
DAVE 
Trump revives Hormuz blockade as Bitcoin slips towards $62K
Bitcoin has slipped over 2% toward $62,000 after President Donald Trump reinstated an Iranian blockade in the Strait of Hormuz and announced new cargo fees for ships crossing the waterway.
Should You Hold Strategy Stock Following Its Bitcoin Monetization Plan?
Strategy's Bitcoin monetization plan boosts liquidity and buyback flexibility, but valuation, weak momentum and funding risks keep caution in focus.
MSTR 
Twin Vee PowerCats shares surge after merger agreement to combine public company with USFM subsidiary
Twin Vee PowerCats (NASDAQ: VEEE) shares surged more than 370% on Monday, trading around $23, after the company announced a definitive agreement for a transformative transaction involving a merger with a subsidiary of USFM Corporation and the privatization of its marine business. Under the agreement, a subsidiary of USFM Corporation, a developer of strategic mineral interests in Greenland, will merge with and into Twin Vee.
VEEE 
How a zeroed oracle signature unlocked $9M from Hedera DeFi lender Bonzo Lend
The verifier accepted identity inputs as proof, letting 250 SAUCE support $9.05 million in principal borrowing.
Why Canadian National (CNI) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CN (CNI) have what it takes?
CNI 
MGE (MGEE) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MGE (MGEE) have what it takes?
MGEE 
First Business Financial Services (FBIZ) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Business Financial Services (FBIZ) have what it takes?
FBIZ 
This is Why Stag Industrial (STAG) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Stag (STAG) have what it takes?
STAG 
Why M&T Bank Corporation (MTB) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does M&T Bank (MTB) have what it takes?
MTB 
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Essent Group (ESNT) have what it takes?
ESNT 
Why Royal Bank (RY) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Royal Bank (RY) have what it takes?
RY 
SB Financial Group, Inc. (SBFG) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does SB Financial Group (SBFG) have what it takes?
SBFG 
Air Products and Chemicals (APD) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?
APD 
Korn/Ferry (KFY) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Korn/Ferry (KFY) have what it takes?
KFY 
HBT Financial (HBT) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does HBT Financial (HBT) have what it takes?
HBT 
First BanCorp (FBP) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First BanCorp (FBP) have what it takes?
FBP 
